The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients
Megan McAleavy, Qian Zhang, Peter J. Ehmann, Jianing Xu, Matthew F. Wipperman, Dharani Ajithdoss, Li Pan, Matthew Wakai, Raphael Simonson, Abhilash Gadi, Adelekan Oyejide, Sara C. Hamon, Anita Boyapati, Lori G. Morton, Tea Shavlakadze, Christos A. Kyratsous, David J. Glass